Ontology highlight
ABSTRACT: Background
The gut bacteria-derived metabolite trimethylamine-N-oxide (TMAO) has been discussed in various cardiometabolic diseases. However, evidence characterizing the microbial population responsible for TMAO accumulation in patients with atrial fibrillation (AF), an increasingly prevalent arrhythmia, is yet lacking. In order to understand the key gut microorganisms that produce TMAO in AF, trimethylamine (TMA)-synthesis enzymes and metabolic pathways, as well as the potential TMA-producers in gut microbiome were assessed based on metagenomic data-mining in a northern Chinese cohort consisting of 50 non-AF controls and 50 patients with different types of AF.Results
Compared to the control subjects, AF patients showed a marked increase in the microbial genes underlying TM
SUBMITTER: Zuo K
PROVIDER: S-EPMC7391570 | biostudies-literature | 2020 Jul
REPOSITORIES: biostudies-literature